TY - JOUR
T1 - Haematological changes in African children who received short-term prophylaxis with nevirapine and zidovudine at birth
AU - Taha, Taha E.
AU - Kumwenda, Newton
AU - Kafulafula, George
AU - Kumwenda, Johnstone
AU - Chitale, Rohit
AU - Nkhoma, Chiwawa
AU - Katundu, Pauline
AU - Mukiibi, Joshua
AU - Chen, Shu
AU - Hoover, Donald
AU - Broadhead, Robin
PY - 2004/12
Y1 - 2004/12
N2 - We ssessed the safety of short-term antiretroviral prophylaxis to prevent mother-to-child transmission (MTCT) of HIV by monitoring haematological changes in children up to the age of 18 months. Babies of HIV-infected women were randomised at birth to receive a single dose of nevirapine (NVP) alone or with zidovudine (ZDV) twice daily for a week. Based on the time of presentation to the labour ward, mothers of these babies might or might not have received intrapartum NVP. Complete blood counts were performed at birth and at 1.5, 3, 6, 9, 12, 15 and 18 months. Babies' HIV status was determined by HIV-1 RNA testing. A total of 1755 babies were included in the study. Age-specific mean haemoglobin levels and prevalence of anaemia (haemoglobin < 10 g/dL) were not significantly different in cases where only the babies received a single dose of NVP and cases where NVP was given to mother/infant pairs or additional ZDV to the baby. Among HIV-infected children compared with uninfected children, the age-specific frequency of anaemia was significantly greater, anaemia started earlier and recovery to normal levels was slower and prolonged. A reversible granulocytopenia was observed in all children between 1.5 and 3 months of age. HIV infection significantly increased the children's risk of death. Antiretroviral prophylaxis appeared to protect against anaemia and child death. Short regimens of antiretrovirals to prevent MTCT of HIV are not associated with long-term adverse haematological changes.
AB - We ssessed the safety of short-term antiretroviral prophylaxis to prevent mother-to-child transmission (MTCT) of HIV by monitoring haematological changes in children up to the age of 18 months. Babies of HIV-infected women were randomised at birth to receive a single dose of nevirapine (NVP) alone or with zidovudine (ZDV) twice daily for a week. Based on the time of presentation to the labour ward, mothers of these babies might or might not have received intrapartum NVP. Complete blood counts were performed at birth and at 1.5, 3, 6, 9, 12, 15 and 18 months. Babies' HIV status was determined by HIV-1 RNA testing. A total of 1755 babies were included in the study. Age-specific mean haemoglobin levels and prevalence of anaemia (haemoglobin < 10 g/dL) were not significantly different in cases where only the babies received a single dose of NVP and cases where NVP was given to mother/infant pairs or additional ZDV to the baby. Among HIV-infected children compared with uninfected children, the age-specific frequency of anaemia was significantly greater, anaemia started earlier and recovery to normal levels was slower and prolonged. A reversible granulocytopenia was observed in all children between 1.5 and 3 months of age. HIV infection significantly increased the children's risk of death. Antiretroviral prophylaxis appeared to protect against anaemia and child death. Short regimens of antiretrovirals to prevent MTCT of HIV are not associated with long-term adverse haematological changes.
UR - http://www.scopus.com/inward/record.url?scp=19944416196&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19944416196&partnerID=8YFLogxK
U2 - 10.1179/027249304225019127
DO - 10.1179/027249304225019127
M3 - Article
C2 - 15720887
AN - SCOPUS:19944416196
SN - 2046-9047
VL - 24
SP - 301
EP - 309
JO - Paediatrics and international child health
JF - Paediatrics and international child health
IS - 4
ER -